Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/30497Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Turan, Belma | - |
| dc.contributor.author | Tuncay, Erkan | - |
| dc.date.accessioned | 2015-02-11T04:23:45Z | - |
| dc.date.available | 2015-02-11T04:23:45Z | - |
| dc.date.issued | 2014-12 | - |
| dc.identifier.issn | 0975-0959 (Online); 0301-1208 (Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/30497 | - |
| dc.description | 483-492 | en_US |
| dc.description.abstract | Beta-adrenoceptors (β-AR), members of the G protein-coupled receptors play important roles in the regulation of heart function. A positive inotropic action of catecholamines is mediated through their interaction with β-AR, located on the sarcolemma, while they can also mediate some deleterious effects, such as cardiac arrhythmias or myocardial apoptosis. The well-known β-AR-associated signaling in heart is composed of a coupled mechanism among both β1- and β2-AR and stimulatory G protein (Gs). This coupled mechanism further leads to the activation of adenylyl cyclase and thereby increases in intracellular cAMP level. However, recent studies have emphasized the contribution of constitutive β3-AR coupling to Gi proteins, thereby initiating additional signal transduction pathways, particularly under physiopathological conditions. Diabetic cardiomyopathy, as a distinct entity is recognized due to its diminished responsiveness to β1-AR agonist stimulation in the heart from diabetic rats with no important changes in the responses mediated with β2-AR. Furthermore, an upregulation of β3-AR has been shown in diabetic rat heart with a strong negative inotropic effect on left ventricular function. Experimental data provide evidences that the mechanisms for the negative inotropic effect with β3-AR activation appear to involve a pertussis toxin (PTX)-sensitive G protein and the activation of a nitric oxide synthase pathway. On the other hand, β-blockers demonstrate marked beneficial effects in heart dysfunction with scavenging free radicals and/or acting as an antioxidant with both sex- and dose-dependent manner. However, further investigations are needed to clarify the roles of both altered expression and/or responsiveness of β-AR and the benefits with β-blocker treatment in diabetes. This review discusses the role of β-AR activation, particularly β3-AR in cardiac pathological remodeling under hyperglycemia. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights | CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | IJBB Vol.51(6) [December 2014] | en_US |
| dc.subject | β-Blockers | en_US |
| dc.subject | β-Adrenoceptor subtypes | en_US |
| dc.subject | Heart function | en_US |
| dc.subject | Oxidative stress | en_US |
| dc.subject | Diabetes mellitus | en_US |
| dc.title | Regulation of Cardiac β3-Adrenergic Receptors in Hyperglycemia | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJBB Vol.51(6) [December 2014] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJBB 51(6) 483-492.pdf | 298.95 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.